Matt has extensive experience in public and private financings, buy-side and sell-side transactions and fairness opinions in the Healthcare sector. Before joining us in 2007, he worked in First Albany's Healthcare Investment Banking Group. Matt was instrumental in building their Healthcare franchise into one of the most active boutique investment banks focused on the Life Sciences sector and was head of their West Coast Investment Banking efforts. Before this, he worked in the mergers and acquisitions group at Robertson Stephens, focusing on the Life Sciences practice and also worked at PaineWebber. Matt graduated with a Master of Business Administration from the University of Virginia and earned a BA from St. Lawrence University.
Selected Transactions
-
En attente d'achèvement
Neuronetics
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
-
US$46m
TELA Bio
Joint Bookrunner (Follow-On Offering)
-
US$207m
CeriBell
Co-Manager (IPO)
-
US$100m
obp Surgical
Financial Advisor to obp Surgical on its Sale to CooperSurgical
-
US$60m
Pulse Biosciences
Lead Agent (ATM Offering)
-
Private Healthcare Devices Company
US$75m
Private Healthcare Devices Company
Exclusive Financial Advisor to the Company on its Balance Sheet Recapitalization
-
US$748m
Merit Medical
Co-Manager (Conv. Notes Offering)
-
US$77m
Venus Concept
Exclusive Financial Advisor (Restructuring)
-
TransMedics
Financial Advisor (Buy side)
